Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their ...

Charles has been in the industry for 19 years now, and has worked with brands such as Autocar India, Overdrive, Motoring World, CarWale, BikeWale and Powerdrift. He has more experience reviewing cars, ...

Beef, coffee and produce were among the items that surged in price, inflation data showed. By Madeleine Ngo Food prices climbed sharply in December, providing little relief to consumers at the grocery ...

Share on Pinterest U.S. drug manufacturers are expected to raise prices on at least 350 prescription medications. Anna Moneymaker/Getty Images A new report states that U.S. drugmakers will increase ...

Anthropic, the developer of the chatbot Claude, plans to raise $10 billion at a valuation of $350 billion before the new investment, according to people familiar with the matter, nearly doubling its ...

Drugmakers plan to raise U.S. prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and blockbuster cancer treatment Ibrance, even as the Trump administration ...

Drugmakers plan to raise U.S. prices on at least 350 branded medications in 2026, including vaccines for COVID-19 and shingles, migraine treatments, and blockbuster cancer drugs, according to data ...

American pharma giant Pfizer (PFE) leads the pack as pharmaceutical companies plan price increases for at least 350 branded medications, according to data seen by Reuters. The move underscores the ...

The costs of at least 350 drugs in the U.S. are expected to rise in 2026, according to a new analysis, despite many of the drugmakers pledging to offer more favorable prices under new Trump ...

Drugmakers are reportedly preparing to raise U.S. prices on at least 350 branded medicines in 2026, including vaccines for COVID-19, RSV, and shingles, as well as major cancer therapies, despite ...

NEW YORK, Dec 31 (Reuters) - Drugmakers plan to raise U.S. prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and blockbuster cancer treatment Ibrance, even ...

Tigress Financial raised the firm’s price target on Nvidia (NVDA) to $350 from $280 and keeps a Strong Buy rating on the shares, which the firm calls “the must-own core holding in the AI investment ...